Published in Cancer on July 15, 2004
Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol (2014) 0.79
Transjugular intrahepatic portosystemic shunts in patients with hepatic malignancy. Semin Intervent Radiol (2005) 0.75
Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma. Cancer Invest (2008) 3.69
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci U S A (2005) 2.96
Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma. J Invest Dermatol (2006) 2.87
Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases. Am J Surg Pathol (2008) 2.58
Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg (2003) 2.49
Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol (2008) 2.48
Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg (2009) 2.44
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res (2008) 2.42
Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol (2008) 2.40
Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer (2002) 2.33
Pulmonary embolism of polymethyl methacrylate during percutaneous vertebroplasty and kyphoplasty. AJR Am J Roentgenol (2004) 2.31
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol (2011) 2.28
Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg (2011) 2.16
Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J (2003) 2.02
Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol (2004) 1.90
Splenic arterial interventions: anatomy, indications, technical considerations, and potential complications. Radiographics (2005) 1.85
Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics (2005) 1.85
Clinical correlates of NRAS and BRAF mutations in primary human melanoma. Clin Cancer Res (2010) 1.78
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer (2005) 1.67
Robot-assisted transaxillary thyroid surgery in the United States: is it comparable to open thyroid lobectomy? Ann Surg Oncol (2011) 1.62
CT-guided percutaneous fine-needle aspiration biopsy of small (< or =1-cm) pulmonary lesions. Radiology (2002) 1.59
Texas hospitals' experience with the Texas Advance Directives Act. Crit Care Med (2007) 1.59
Outcomes in lymphoma patients with obstructive jaundice: a cancer center experience. Dig Dis Sci (2010) 1.44
Salvage surgery after energy ablation for renal masses. BJU Int (2015) 1.43
Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol (2005) 1.43
Is embolization of segment 4 portal veins before extended right hepatectomy justified? Surgery (2008) 1.41
Percutaneous intraportal application of adipose tissue-derived mesenchymal stem cells using a balloon occlusion catheter in a porcine model of liver fibrosis. J Vasc Interv Radiol (2013) 1.40
Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer (2010) 1.40
Laser-induced thermal therapy for tumor ablation. Crit Rev Biomed Eng (2010) 1.37
Transhepatic portal vein embolization: anatomy, indications, and technical considerations. Radiographics (2002) 1.33
Technical aspects of radioembolization with 90Y microspheres. Tech Vasc Interv Radiol (2007) 1.31
Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol (2006) 1.30
Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine? J Urol (2003) 1.29
P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy. Oncotarget (2013) 1.26
Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg (2007) 1.25
Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol (2006) 1.23
Comparison of two methods of future liver remnant volume measurement. J Gastrointest Surg (2007) 1.21
Angiogenesis-promoting gene patterns in alveolar soft part sarcoma. Clin Cancer Res (2007) 1.18
The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer (2002) 1.18
Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol (2005) 1.18
Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. J Vasc Interv Radiol (2007) 1.13
Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems. Eur Radiol (2003) 1.11
Small (</=2-cm) subpleural pulmonary lesions: short- versus long-needle-path CT-guided Biopsy--comparison of diagnostic yields and complications. Radiology (2005) 1.11
Arterioureteral fistulas: a clinical, diagnostic, and therapeutic dilemma. AJR Am J Roentgenol (2004) 1.09
Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes. Cancer (2007) 1.08
Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. Surgery (2009) 1.07
Imaging-guided percutaneous biopsy of mediastinal lesions: different approaches and anatomic considerations. Radiographics (2005) 1.06
Re: portal vein embolization: what do we know? Cardiovasc Intervent Radiol (2012) 1.05
Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection. Ann Surg Oncol (2008) 1.05
Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol (2005) 1.02
Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J Vasc Interv Radiol (2005) 1.00
Primary malignant pancreatic neoplasms in children and adolescents: a 20 year experience. J Pediatr Surg (2012) 0.99
Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis. Clin Cancer Res (2007) 0.98
Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol (2008) 0.97
Handheld histology-equivalent sectioning laser-scanning confocal optical microscope for interventional imaging. Biomed Microdevices (2010) 0.96
Preoperative portal vein embolization: an approach to improve the safety of major hepatic resection. Semin Roentgenol (2011) 0.96
Masses in or around the pancreatic head: CT-guided coaxial fine-needle aspiration biopsy with a posterior transcaval approach. Radiology (2002) 0.96
Percutaneous image-guided splenic biopsy in the oncology patient: an audit of 156 consecutive cases. J Vasc Interv Radiol (2008) 0.96
Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia. Am J Surg Pathol (2008) 0.96
Patterns of intervention for renal lesions in von Hippel-Lindau disease. BJU Int (2008) 0.95
Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors. Cancer (2006) 0.95
Dr. Gary J. Becker Young Investigator Award: intraarterial adenovirus for metastatic gastrointestinal cancer: activity, radiographic response, and survival. J Vasc Interv Radiol (2003) 0.93
Various approaches for CT-guided percutaneous biopsy of deep pelvic lesions: anatomic and technical considerations. Radiographics (2004) 0.93
The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer. Oncologist (2012) 0.92
Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int (2009) 0.92
TIPS-related hepatic encephalopathy: management options with novel endovascular techniques. Radiographics (2004) 0.92
Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target. J Pathol (2011) 0.91
Fistulas of the lower urinary tract: percutaneous approaches for the management of a difficult clinical entity. Radiographics (2004) 0.90
Percutaneous portal vein access and transhepatic tract hemostasis. Semin Intervent Radiol (2012) 0.90
Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol (2008) 0.90
Safety and diagnostic accuracy of percutaneous biopsy in upper tract urothelial carcinoma. BJU Int (2014) 0.90
Locally ablative therapies for primary and metastatic liver cancer. Expert Rev Anticancer Ther (2014) 0.89
Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors. Am J Clin Oncol (2009) 0.89
Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer. Horm Cancer (2010) 0.89
Percutaneous biopsy of head and neck lesions with CT guidance: various approaches and relevant anatomic and technical considerations. Radiographics (2007) 0.89
Preoperative portal vein embolization: indications and technical considerations. Tech Vasc Interv Radiol (2007) 0.88
Image-guided percutaneous needle biopsy in cancer diagnosis and staging. Tech Vasc Interv Radiol (2007) 0.88
Use of inferior vena caval filters and survival in patients with malignancy. Cancer (2004) 0.88
Portal vein embolization in hilar cholangiocarcinoma. Surg Oncol Clin N Am (2009) 0.88
Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancer. Horm Cancer (2011) 0.87
Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases. Cardiovasc Intervent Radiol (2007) 0.87
Phase I trial of hepatic arterial infusion of nanoparticle albumin-bound paclitaxel: toxicity, pharmacokinetics, and activity. Mol Cancer Ther (2011) 0.86
Development of a large animal model for lung tumors. J Vasc Interv Radiol (2002) 0.86